|
Rite Aid Corp
RAD's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Rite Aid's sales fell
by -4.32 % in II. Quarter 2023 from the same quarter a year ago.
Ranking at No. 2677
Pharmacy Services & Retail Drugstore industry recorded
growth of revenues by 10.93 %
Rite Aid net loss increased from $-331 millions, to $-1,010 millions in II. Quarter 2023,
• More on RAD's Growth
|
|
Rite Aid realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.78 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
19.13 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.19.
• More on RAD's Valuation
|
|
|
|
|
Rite Aid realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.78 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
19.13 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.19.
• More on RAD's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com